Nawana, named to succeed Olivier Bohuon last year, is stepping down effective Nov. 1 “to pursue other opportunities outside of the U.K.,” the London-based healthcare giant said. Nawana is slated to stay on until Dec. 31 to assist in the transition.
“On behalf of the board, I am delighted to welcome Roland Diggelmann as Smith & Nephew’s incoming CEO. I am certain that Roland’s leadership qualities, combined with his excellent track record of delivering results in an innovation-led business, his deep expertise in the medical devices industry, and his knowledge of Smith & Nephew, make him the right person to build on the Company’s success into the future,” chairman Roberto Quarta said in prepared remarks. “During his time with Smith & Nephew, Namal has substantially transformed the business with a new strategy, purpose and culture, and renewed commitment to innovation, returning it to an improved growth trajectory. I would like to thank Namal for his leadership and many contributions to the Company, our employees, customers and stakeholders.”
“I am honored to have been asked to lead Smith & Nephew at an exciting time for the business. As non-executive director I have seen first-hand the strength of the group’s people and its portfolio of leading technologies. I look forward to playing my part in shaping the future of the company and driving the next stage of growth,” Diggelmann added.
“There is clear momentum behind our strategy laid out last year, underlined by the company’s performance generated by our team during 2019. I am proud to be leaving Smith & Nephew in a strong position for the next phase of its development,” Nawana said.
Browne named president & CEO at Xtant
Earlier this month, Xtant Medical (NYSE:XTNT) tabbed Sean Browne to be its next president & CEO, effective immediately. Brown has over three decades of experience in the industry, having previously served as chief revenue officer of CCS Medical. The company expects Browne to join the board of directors after its October 30 stockholder meeting.
Salmon takes over Medtronic diabetes group
Medtronic (NYSE:MDT) said today that Sean Salmon has been named EVP and group president of Medtronic diabetes, effective today. Salmon is set to replace Hooman Hakami, who is leaving the company. Previously, Salmon was an SVP and president of coronary and structural heart within Medtronic’s cardiac & vascular group.
Driscoll to be interim CFO at ConforMIS
Last week, ConforMIS (NSDQ:CFMS) announced the interim appointment of Frederick Driscoll to its CFO position, effective immediately. Driscoll takes over for Paul Weiner, whose resignation was previously announced and went into effect on October 18.
Matthews out as Forward Industries COO
Forward Industries announced last week that COO Doug Matthews’ employment agreement would not be renewed beyond its initial six-month probationary period.
- Accuray picks Winter as SVP, chief commercial officer
- Panzarella to be new chief commercial officer at Magnetic Insight
- Jarow named CMO at Francis Medical
- Google names former HHS offical DiSalvo chief health officer
- Lorenzo, Goode appointed to Orchestra BioMed product development roles
- Armijo named VP of operations at Imperative Care
- Pi-Cardia picks former CoreValve founder & CEO Séguin as chairman of its board of directors